CLOV – clover health investments, corp. - class a common stock (US:NASDAQ)
Stock Stats
News
MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value
Clover Health Investments (CLOV) had its price target lowered by Canaccord Genuity Group Inc. from $3.70 to $3.20. They now have a "buy" rating on the stock.
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
Clover Health Investments Touts AI Medicare Advantage Model, Targets GAAP Profitability in 2026 at Leerink Conference [Yahoo! Finance]
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives [Yahoo! Finance]
Form SCHEDULE 13G/A CLOVER HEALTH INVESTMENT Filed by: VANGUARD GROUP INC
Form 4 CLOVER HEALTH INVESTMENT For: Mar 18 Filed by: Reynoso Jamie L.
Form 144 CLOVER HEALTH INVESTMENT Filed by: Reynoso Jamie L.
Form 4 CLOVER HEALTH INVESTMENT For: Mar 14 Filed by: Reynoso Jamie L.
Form 4 CLOVER HEALTH INVESTMENT For: Mar 15 Filed by: Soares Karen
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.